# Mark Pletscher

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-pletscher/

## Facts

| Field | Value |
| --- | --- |
| Citations | 336 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 9 |
| i10-index | 9 |
| Last Known Institution | Novartis (Switzerland) |
| OpenAlex ID | https://openalex.org/A5052347465 |
| ORCID iD | 0000-0003-2134-4542 |
| Works | 56 |

## Researcher papers

- [How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts](https://scholariq.org/papers/how-much-does-the-treatment-of-each-major-disease-cost-a-decomposition-of-swiss/)
- [Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland](https://scholariq.org/papers/cost-effectiveness-of-dabigatran-for-stroke-prevention-in-atrial-fibrillation-in/)
- [Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine](https://scholariq.org/papers/cost-effectiveness-of-hla-dqb1-hla-b-pharmacogenetic-guided-treatment-and-blood/)
- [Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease](https://scholariq.org/papers/cost-effectiveness-of-functional-cardiac-imaging-in-the-diagnostic-work-up-of/)
- [Cost of acute coronary syndrome in Switzerland in 2008](https://scholariq.org/papers/cost-of-acute-coronary-syndrome-in-switzerland-in-2008/)
- [Health utility indexes in patients with acute coronary syndromes](https://scholariq.org/papers/health-utility-indexes-in-patients-with-acute-coronary-syndromes/)
- [Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma](https://scholariq.org/papers/combined-treatment-with-zidovudine-and-lymphoblast-interferon-alpha-in-patients/)
- [The Societal Costs of Schizophrenia in Switzerland](https://scholariq.org/papers/the-societal-costs-of-schizophrenia-in-switzerland/)
- [The effects of organized screening programs on the demand for mammography in Switzerland](https://scholariq.org/papers/the-effects-of-organized-screening-programs-on-the-demand-for-mammography-in/)
- [Die Kosten der nichtübertragbaren Krankheiten in der Schweiz : Schlussbericht](https://scholariq.org/papers/die-kosten-der-nichtubertragbaren-krankheiten-in-der-schweiz-schlussbericht/)
- [Health Care Resource Utilization and Productivity Impairment in Adults with Immunoglobulin A Nephropathy: A Real-World, Observational, Global Analysis](https://scholariq.org/papers/health-care-resource-utilization-and-productivity-impairment-in-adults-with/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Health and Medical Studies](https://scholariq.org/topics/health-and-medical-studies/)
- [Global Health Care Issues](https://scholariq.org/topics/global-health-care-issues/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Health Promotion and Cardiovascular Prevention](https://scholariq.org/topics/health-promotion-and-cardiovascular-prevention/)

## Researcher university

- [Novartis (Switzerland)](https://scholariq.org/institutions/novartis-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.